MetLife Investment Management’s ASP Isotopes ASPI Stock Holding History
Bought
Maintained
Sold
Other funds holding ASPI
RIM
AIC
MetLife Investment Management's ASPI Position: Q2 2026 in Review
MetLife Investment Management increased its ASP Isotopes (ASPI) stake by 9.7% in Q2 2026, buying an estimated $36.1K and bringing the position to 69,727 shares worth $434K. The position accounts for ﹤0.01% of the portfolio, ranked #1992.
MetLife Investment Management first reported a position in ASPI in Q3 2024 and has held it in 8 quarters since. The position peaked at $440K in Q3 2025. 185 funds tracked by Wall St. Rank hold ASPI as of Q2 2026.
- MetLife Investment Management held 69,727 shares of ASP Isotopes worth $434K as of Q2 2026.
- MetLife Investment Management bought 6,140 ASP Isotopes shares in Q2 2026, an estimated $36.1K.
- ASP Isotopes made up ﹤0.01% of MetLife Investment Management's portfolio in Q2 2026, its #1992 holding.
- MetLife Investment Management first reported a position in ASP Isotopes in Q3 2024 and has held it in 8 quarters since.
- MetLife Investment Management's ASP Isotopes position peaked at $440K in Q3 2025.
- 185 funds tracked by Wall St. Rank held ASP Isotopes as of Q2 2026.
Based on MetLife Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.